IP Library Granted Patent US 8,003,828
Granted Patent B2
US 8,003,828 · App. 10/483,603 · Granted Aug 23, 2011

Method of producing reduced coenzyme Q

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,003,828
App. No.
10/483,603
Granted
Aug 23, 2011
Kind
B2
Abstract

The present invention provides a method of producing reduced coenzyme Q 10 crystals suitable for commercial scale production thereof. According to a method of the present invention of producing a reduced coenzyme Q 10 crystal which comprises a crystallization of reduced coenzyme Q 10 in a solution of alcohols and/or ketones, reduced coenzyme Q 10 crystal excellent in slurry properties and crystalline properties maybe obtained. Moreover, an isolation process including a crystal separation or the whole process including the isolation process maybe minimized and simplified. Thus, highly pure reduced coenzyme Q 10 may be obtained in a high yield.

Claims (24)

1. A method of producing reduced coenzyme Q 10 crystals on a commercial scale,

which comprises crystallizing reduced coenzyme Q 10 in a solution of an alcohol and/or a ketone wherein the ratio of the alcohol and/or ketone in a solvent is at least 80 w/w %, and the crystallization concentration as expressed in terms of the weight of reduced coenzyme Q 10 based on the weight of a crystallization solvent at the time of completion of crystallization is 1 to 15 w/w %,

wherein crystallization is carried by cooling or a combination of crystallization by cooling with another method of crystallization,

wherein the crystallization is carried out in a deoxygenated atmosphere and under forced flowing caused by a power required for stirring per unit volume of not weaker than 0.01 kW/m 3 ,

and wherein the crystallization is carried out at a cooling rate of 20° C./hour or less and at a cooling temperature of 20° C./hour or less.

2. The method according to claim 1 , wherein reduced coenzyme Q 10 is crystallized in a solution of an alcohol.

3. The method according to claim 2 , wherein the alcohol is a monohydric alcohol containing 1 to 20 carbon atoms.

4. The method according to claim 2 , wherein the alcohol is a monohydric alcohol containing 1 to 5 carbon atoms.

5. The method according to claim 4 , wherein the monohydric alcohol containing 1 to 5 carbon atoms is ethanol.

6. The method according to claim 1 , wherein reduced coenzyme Q 10 is crystallized in a solution of a ketone.

7. The method according to claim 1 , wherein the ketone is a ketone containing 3 to 6 carbon atoms.

8. The method according to claim 7 , wherein the ketone containing 3 to 6 carbon atoms is acetone.

9. The method according to claim 1 , wherein water is used as an auxiliary solvent.

10. The method according to claim 9 , wherein the ratio of an alcohol and/or a ketone in the solvent is 90 to 99.5 w/w %.

11. The method according to claim 1 , wherein a seed crystal is added in carrying out the crystallization.

12. The method according to claim 1 , wherein an impurity is eliminated into the mother liquor.

13. The method according to claim 12 , wherein the impurity to be eliminated is at least one species selected from among reduced coenzyme Q 9 , reduced coenzyme Q 8 and reduced coenzyme Q 7 .

14. The method according to claim 1 , wherein the solution of reduced coenzyme Q 10 in an alcohol and/or a ketone is obtainable by carrying out solvent substitution of a solution prepared by dissolving reduced coenzyme Q 10 in at least one species of solvents selected from hydrocarbons, fatty acid esters, ethers and nitrites with an alcohol and/or a ketone.

15. The method according to claim 14 , wherein the solution prepared by dissolving reduced coenzyme Q 10 in at least one species of solvents selected from hydrocarbons, fatty acid esters, ethers and nitrites is obtainable by reducing oxidized coenzyme Q 10 using at least one species selected from metal hydride compounds, iron, zinc, dithionous acid or salts thereof, and ascorbic acid or a related compound thereof as a reducing agent together with at least one species selected from hydrocarbons, fatty acid esters, ethers and nitrites as a solvent, then recovering an organic phase containing the generated reduced coenzyme Q 10 , and optionally further washing the organic phase with water.

16. The method according to claim 15 , wherein the hyposulfurous acid dithionous acid or the salt thereof is used as the reducing agent.

17. The method according to claim 16 , wherein the reduction is carried out in the presence of water at pH 3 to 7.

18. The method according to claim 15 , wherein ascorbic acid or a related compound thereof is used as the reducing agent.

19. The method according to claim 15 , wherein the reduction is carried out in a deoxygenated atmosphere.

20. The method according to claim 1 , wherein the cooling temperature in the step of crystallization is 15° C. or less.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →